Hoth Therapeutics Inc. (HOTH)
Market Open
12 Jun, 14:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 41
-0.07
-5.0676%
$
28.37M Market Cap
- P/E Ratio
- Div Yield
9.22M Volume
-1.81 Eps
$ 1.48
Previous Close Investors:
Want to track HOTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal
Hoth stock soars as a mid-stage study meets the goal, showing significant improvement in skin toxicities related to EFGR inhibitor therapy in all HT-001-treated patients.
Zacks | 1 year ago
Hoth Stock Up as Lead Drug Heals Skin Toxicities in Cancer Patient
HOTH stock soars on superior efficacy data from the first patient treated with the lead candidate, HT-001, suffering from EGFRI-related skin toxicities.
Zacks | 1 year ago
Why Is Hoth Therapeutics (HOTH) Stock Moving Today?
Hoth Therapeutics (NASDAQ: HOTH ) stock is on the move Wednesday after the clinical-stage biopharmaceutical company announced a new partnership with LTS Therapy Systems. This partnership has the two companies working together to accelerate the development of Hoth Therapeutics' candidate for Alzheimer's disease.
Investorplace | 1 year ago
